" /> Vericiguat - CISMeF





Preferred Label : Vericiguat;

NCIt definition : An orally bioavailable stimulator of soluble guanylate cyclase (sGC), with vasodilating activity. Upon oral administration, vericiguat directly stimulates the catalytic activity of sGC and increases the formation of the intracellular second messenger cyclic guanosine monophosphate (cGMP), which is derived from guanosine triphosphate (GTP). This results in smooth muscle relaxation and vasodilation. sGC, a heme-containing cytoplasmic signaling enzyme, catalyzes the formation of cGMP from GTP in response to nitric oxide (NO) binding to heme. Vericiguat stimulates sGC independently of and synergistically with NO.;

UNII : LV66ADM269;

InChIKey : QZFHIXARHDBPBY-UHFFFAOYSA-N;

CAS number : 1350653-20-1;

Drug name : Verquvo;

Molecule name : BAY-1021189; MK-1242;

NCI Metathesaurus CUI : CL554066;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
05/07/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.